EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucoselysine, a unique advanced glycation end-product of the polyol pathway and its association with vascular complications in type 2 diabetes

Hiroko Yamaguchi, Takeshi Matsumura, Hikari Sugawa, Naoko Niimi, Kazunori Sango, Ryoji Nagai

Journal of Biological Chemistry · 2024

DOI: 10.1016/j.jbc.2024.107479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Hiroko Yamaguchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Food and Regulation Biology, Graduate School of Bioscience, Tokai University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycation End Products, Advanced. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tokai University, Agricultural Research Institute, JSPS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucoselysine (GL) is an unique advanced glycation end-product derived from fructose. The main source of fructose in vivo is the polyol pathway, and an increase in its activity leads to diabetic complications. Here, we aimed to demonstrate that GL can serve as an indicator of the polyol pathway activity. Additionally, we propose a novel approach for detecting GL in peripheral blood samples using liquid chromatography-tandem mass spectrometry and evaluate its clinical usefulness. We successfully circumvent interference from fructoselysine, which shares the same molecular weight as GL, by performing ultrafiltration and hydrolysis without reduction, successfully generating adequate peaks for quantification in serum. Furthermore, using immortalized aldose reductase KO mouse Schwann cells, we demonstrate that GL reflects the downstream activity of the polyol pathway and that GL produced intracellularly is released into the extracellular space. Clinical studies reveal that GL levels in patients with type 2 diabetes are significantly higher than those in healthy participants, while Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine (MG-H1) levels are significantly lower. Both GL and MG-H1 show higher values among patients with vascular complications; however, GL varies more markedly than MG-H1 as well as hemoglobin A1c, fasting plasma glucose, and estimated glomerular filtration rate. Furthermore, GL remains consistently stable under various existing drug treatments for type 2 diabetes, whereas MG-H1 is impacted. To the best of our knowledge, we provide important insights in predicting diabetic complications caused by enhanced polyol pathway activity via assessment of GL levels in peripheral blood samples from patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glycation End Products, AdvancedHumansAnimalsMiceMaleMiddle AgedFemaleLysineOrnithineAldehyde ReductaseDiabetic AngiopathiesPolymersAgedMice, KnockoutImidazoles

Stichwörter der Autor:innen

advanced glycation end-products (AGEs)aldose reductasebiomarkerblooddiabetesfructoseglucose metabolismglucoselysinehyperglycemiamass spectrometry (MS)polyol pathway

Substanzen

Glycation End Products, AdvancedpolyolLysineOrnithineAldehyde ReductaseNdelta-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithinePolymersImidazoles

Autor:innen und Institutionen

  • Laboratory of Food and Regulation Biology, Graduate School of Bioscience, Tokai University, Kumamoto, Japan.
  • Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Laboratory of Food and Regulation Biology, Department of Food and Life Science, School of Agriculture, Tokai University, Kumamoto, Japan.
  • Diabetic Neuropathy Project, Department of Diseases and Infection, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Laboratory of Food and Regulation Biology, Graduate School of Bioscience, Tokai University, Kumamoto, Japan; Laboratory of Food and Regulation Biology, Department of Food and Life Science, School of Agriculture, Tokai U…

Förderung

  • Tokai University
  • Agricultural Research Institute
  • JSPS
  • Japan Society for the Promotion of Science

Zitieren

APA

Yamaguchi, H., Matsumura, T., Sugawa, H., Niimi, N., Sango, K., & Nagai, R. (2024). Glucoselysine, a unique advanced glycation end-product of the polyol pathway and its association with vascular complications in type 2 diabetes. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107479

Vancouver

Yamaguchi H, Matsumura T, Sugawa H, Niimi N, Sango K, Nagai R. Glucoselysine, a unique advanced glycation end-product of the polyol pathway and its association with vascular complications in type 2 diabetes. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107479

BibTeX
@article{Yamaguchi2024,
  author = {Yamaguchi, Hiroko and Matsumura, Takeshi and Sugawa, Hikari and Niimi, Naoko and Sango, Kazunori and Nagai, Ryoji},
  title = {Glucoselysine, a unique advanced glycation end-product of the polyol pathway and its association with vascular complications in type 2 diabetes},
  journal = {Journal of Biological Chemistry},
  year = {2024},
  doi = {10.1016/j.jbc.2024.107479}
}
Kostenlos starten →